Floatz logo

PREDNISONE TABLETS

Leukemia, T-Cell

Children's Oncology GroupSmall moleculePhase 2Dormant
B
60/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
45/ 100
Competitive Position
95/ 100

Competitive context

2 Active assets in the Leukemia, T-Cell cohort.

Asset / SponsorPhaseRating
Cytosin-Arabinosid
Children's Oncology Group
Phase 2B
Solu-Cortef
Children's Oncology Group
Phase 2B
Cyclophosphamide
Xinqiao Hospital of Chongqing
Phase 2B
METHOTREXATE
Children's Oncology Group
Phase 2B
(+)-VINCRISTINE
Children's Oncology Group
Phase 2B

View all 20 →

Same molecule, other indications

PREDNISONE TABLETS is also rated in:

Recurrent Adult T-cell Leukemia/LymphomaDormant
BBB
Indicative ·
76 / 100
View asset →
diffuse large B-cell lymphomaDormant
BBB
Indicative ·
74 / 100
View asset →
metastatic prostate carcinomaDormant
BBB
Indicative ·
74 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →